Valuation: Olympus Corporation

Market Cap 1,926B 11.77B 10.35B 9.63B 8.84B 16.61B 1,129B 16.83B 114B 44.71B 557B 44.18B 43.23B P/E 2027 *
19.9x
P/E 2028 * 16.6x
Enterprise Value 1,997B 12.2B 10.72B 9.98B 9.17B 17.22B 1,170B 17.44B 119B 46.35B 578B 45.79B 44.81B EV / Sales 2027 *
1.87x
EV / Sales 2028 * 1.79x
Free-Float
94.53%
Yield 2027 *
1.7%
Yield 2028 * 1.78%
1 day+4.86%
1 week+2.37%
Current month+6.74%
1 month+7.69%
3 months+18.65%
6 months-1.79%
Current year-8.62%
1 week 1,703
Extreme 1703
1,819.5
1 month 1,636
Extreme 1636
1,819.5
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+4.86%+2.37%+1.45%-19.49% 11.22B
-1.54%+5.08%+16.98%-2.59% 211B
+2.61%-3.60%-4.37%-25.81% 135B
+5.73%+3.30%-28.04%+8.34% 119B
+2.85%+3.36%-57.12%-13.15% 65.77B
+0.50%-3.14%+3.80%-9.37% 47.58B
+1.43%+1.25%-25.87%-31.67% 44.44B
-0.49%+4.89%+14.74%+7.33% 39.14B
-0.93%+0.60%+22.53%+28.04% 36.79B
-2.38%+1.51%+73.35%-0.90% 29.37B
Average +1.26%+0.37%+1.74%-5.93% 73.93B
Weighted average by Cap. +1.24%+0.74%-2.02%-6.32%

Financials

2027 *2028 *
Net sales 1,067B 6.52B 5.73B 5.33B 4.9B 9.2B 625B 9.32B 63.39B 24.76B 309B 24.47B 23.94B 1,108B 6.77B 5.95B 5.54B 5.09B 9.55B 649B 9.68B 65.85B 25.72B 321B 25.41B 24.87B
Net income 98.73B 603M 530M 494M 453M 851M 57.85B 862M 5.87B 2.29B 28.56B 2.26B 2.22B 118B 719M 632M 589M 541M 1.01B 68.97B 1.03B 7B 2.73B 34.06B 2.7B 2.64B
Net Debt 70.42B 430M 378M 352M 323M 607M 41.26B 615M 4.19B 1.63B 20.37B 1.62B 1.58B 52.07B 318M 280M 260M 239M 449M 30.51B 455M 3.09B 1.21B 15.06B 1.19B 1.17B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-27 JP¥1,813.50 +4.86% 5,527,300
26-07-24 JP¥1,729.50 +0.38% 3,047,700
26-07-23 JP¥1,723.00 -0.17% 4,138,900
26-07-22 JP¥1,726.00 -1.65% 4,597,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,813.50JPY
Average target price
1,913.08JPY
Spread / Average Target
+5.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock